Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway

Autor: Fabiany da Costa Gonçalves, Fernanda Visioli, Natalia S. Nunes, Scott R. Burks, Joseph A. Frank, Parwathy Chandran, Maggie Sundby, Ana Helena da Rosa Paz
Rok vydání: 2019
Předmět:
Acute ulcerative colitis
α7 nicotinic acetylcholine receptor
Proteomics
0301 basic medicine
medicine.medical_specialty
Research paper
alpha7 Nicotinic Acetylcholine Receptor
Ultrasonic Therapy
Therapeutic ultrasound
Gastroenterology
Inflammatory bowel disease
General Biochemistry
Genetics and Molecular Biology

Mice
03 medical and health sciences
0302 clinical medicine
Immune system
Cholinergic anti-inflammatory pathway
Internal medicine
medicine
Animals
Humans
Colitis
Acute colitis
Peroxidase
Inflammation
Mice
Knockout

Dextran Sulphate sodium
business.industry
Macrophages
Dextran Sulfate
Acute kidney injury
General Medicine
Inflammatory Bowel Diseases
medicine.disease
Ulcerative colitis
3. Good health
Disease Models
Animal

030104 developmental biology
030220 oncology & carcinogenesis
Cytokines
Cholinergic
business
Zdroj: EBioMedicine
ISSN: 2352-3964
DOI: 10.1016/j.ebiom.2019.06.033
Popis: Background Ulcerative Colitis (UC) is an Inflammatory Bowel Disease (IBD) characterized by uncontrolled immune response, diarrhoea, weight loss and bloody stools, where sustained remission is not currently achievable. Dextran Sulphate Sodium (DSS)-induced colitis is an animal model that closely mimics human UC. Ultrasound (US) has been shown to prevent experimental acute kidney injury through vagus nerve (VN) stimulation and activation of the cholinergic anti-inflammatory pathway (CAIP). Since IBD patients may present dysfunctional VN activity, our aim was to determine the effects of therapeutic ultrasound (TUS) in DSS-induced colitis. Methods Acute colitis was induced by 2% DSS in drinking water for 7 days and TUS was administered to the abdominal area for 7 min/day from days 4–10. Clinical symptoms were analysed, and biological samples were collected for proteomics, macroscopic and microscopic analysis, flow cytometry and immunohistochemistry. Findings TUS attenuated colitis by reducing clinical scores, colon shortening and histological damage, inducing proteomic tolerogenic response in the gut during the injury phase and early recovery of experimental colitis. TUS did not improve clinical and pathological outcomes in splenectomised mice, while α7nAChR (α7 nicotinic acetylcholine receptor - indicator of CAIP involvement) knockout animals presented with disease worsening. Increased levels of colonic F4/80+α7nAChR+ macrophages in wild type mice suggest CAIP activation. Interpretation These results indicate TUS improved DSS-induced colitis through stimulation of the splenic nerve along with possible contribution by VN with CAIP activation. Fund Intramural Research Programs of the Clinical Centre, the National Institute of Biomedical Imaging and Bioengineering at the NIH and CAPES/Brazil.
Graphical abstract Unlabelled Image
Databáze: OpenAIRE